According to Aurobindo Pharma 's latest financial reports the company's current EPS (TTM) is $0.41. In 2022 the company made an earnings per share (EPS) of $0.43 a decrease over its 2021 EPS that were of $0.66.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $0.41 | -4.26% |
2022 | $0.43 | -35.02% |
2021 | $0.66 | -46.99% |
2020 | $1.25 | 99.38% |
2019 | $0.63 | 9.65% |
2018 | $0.57 | -10.99% |
2017 | $0.64 | 8.1% |
2016 | $0.59 | 19.49% |
2015 | $0.50 | 5.35% |
2014 | $0.47 | 113.97% |
2013 | $0.22 | 125.37% |
2012 | $0.09759 |